Fractyl Laboratories rallies $55m Series E

Lexington, Massachusetts-based Fractyl Laboratories Inc, a life sciences company focused on reversing the metabolic disease epidemic, has raised $55 million in Series E financing.

ByIris Dorbian

6 August 2020•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals Healthcare Briefs

Fractyl Laboratories rallies $55m Series E

Bessemer Venture Partners

Catalio Capital Management

Domain Associates

Emergent Medical Partners

General Catalyst Partners

True Ventures

Related articles